SAFETY AND EFFICACY OF GEN3009 (DUOHEXABODY®-CD37) IN RELAPSED OR REFRACTORY B-CELL NON-HODKIN LYMPHOMA A FIRST-IN-HUMAN, OPEN-LABEL, PHASE I/II A DOSE ESCALATION TRIAL WITH DOSE EXPANSION COHORTS
2019-002752-16LINFOMA NO HODKIN DE CELULAS B RECIDIVANTE O RESISTENTEFundación Jiménez DíazInvestigador: CORDOBA MASCUÑANO RAUL
